November 24, 2014 4:47 PM ET

Biotechnology

Company Overview of Innovir Laboratories Inc.

Company Overview

As per the transaction announced in August 1999, Innovir Laboratories, Inc. was acquired by Sirna Therapeutics Inc. Innovir Laboratories, Inc. develops technology to be used as a research tool to facilitate determination of gene function, and to validate drug targets. The company continues to seek partners, investors or purchasers for its core oligozyme technology including the lead EGS, the FRS/GSFRS, the RILON technology and related research technologies. Innovir has no commercially viable therapeutic products, and does not anticipate having any for several years. Since its inception, substantially all of its resources have been applied to research and development, patents and licensing, a...

510 E 73rd St

New York, NY 10021

United States

44 Employees

Phone:

212-249-4703

Key Executives for Innovir Laboratories Inc.

Innovir Laboratories Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Adaptive Therapeutics, Inc. United States
AndroBioSys, Inc. United States
Abraxis Bioscience International Holding Co., Inc. United States
LiRIS Biomedical, Inc. United States
GenWay Biotech, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Innovir Laboratories Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.